Background: Percutaneous penetration of urea in vivo in man has been documented. If urea can penetrate the skin, it may also move laterally. Lateral spreading of topical substances leads to unpredictable penetration dynamics and increased skin surface area exposure. Methods: The ability of urea, a low molecular-weight hydrophilic model, to penetrate the stratum corneum (SC) and spread outside the application site was investigated in vitro using tape stripping with spectroscopy. The parameters investigated were the following: time between urea application and tape stripping, formulations containing urea and use of a petrolatum-covered ring barrier around the marked application area. Results: The percentage of urea was determined in and around the application site. The spreading of topically applied urea to neighboring areas occurred and was time but not formulation dependent. A significant difference between protocols with and without the petrolatum ring was observed. Conclusion: These results suggest the clinical importance of lateral spreading, occurring predominately on the skin surface. SC thickness varies between anatomical sites, predisposing areas such as the face and scalp margins to increased percutaneous penetration of topical products. The use of a protective petrolatum ring can inhibit lateral spreading of hair dye in individuals allergic to hair dye, limit systemic absorption and increase accuracy when assessing penetration dynamics. © 2014 S. Karger AG, Basel

1.
Surber C, Davis AF: Bioavailability and bioequivalence of dermatological formulations; in Walters KA (ed): Dermatological and Transdermal Formulations. New York, Decker, 2002, pp 401-498.
2.
Gee CM, Watkinson AC, Nicolazzo JA, Finnin BC: The effect of formulation excipients on the penetration and lateral diffusion of ibuprofen on and within the stratum corneum following topical application to humans. J Pharm Sci 2014;103:909-919.
3.
Moser K, Kriwet K, et al: Passive skin penetration enhancement and its quantification in vitro. Eur J Pharm Biopharm 2001;52:103-112.
4.
Löffler H, Dreher F, et al: Stratum corneum adhesive tape stripping: influence of anatomical site, application pressure, duration and removal. Br J Dermatol 2004;151:746-752.
5.
Dreher F, Modjtahedi BS, et al: Quantification of stratum corneum removal by adhesive tape stripping by total protein assay in 96-well microplates. Skin Res Tech 2005;11:97-101.
6.
Lodén M: Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. Am J Clin Dermatol 2003;4:771-788.
7.
Leite e Silva VR, Schulman MA, et al: Hydrating effects of moisturizer active compounds incorporated into hydrogels: in vivo assessment and comparison between devices. J Cosmet Dermatol 2009;8:32-39.
8.
Williams AC, Barry BW, et al: Penetration enhancers. Adv Drug Deliv Rev 2004;56:603-618.
9.
Trommer H, Neubert RH: Overcoming the stratum corneum: the modulation of skin penetration. Skin Pharmacol Physiol 2006;19:106-121.
10.
Feldmann RJ, Maibach HI: Percutaneous penetration of hydrocortisone with urea. Arch Dermatol 1974;109:58-59.
11.
Schölermann A, Banké-Bochita J, et al: Efficacy and safety of Eucerin 10% urea lotion in the treatment of symptoms of aged skin. J Dermatol Treat 1998;9:175-179.
12.
Godwin DA, Player MR, et al: Synthesis and investigation of urea compounds as transdermal penetration enhancers. Int J Pharm 1998;167:165-175.
13.
Feldmann RJ, Maibach HI: Absorption of some organic compounds through the skin in man. J Invest Dermatol 1970;54:399-404.
14.
Wellner K, Wohlrab W: Quantitative evaluation of urea in stratum corneum of human skin. Arch Dermatol Res 1993;285:239-240.
15.
Lugosi R, Thibert RJ, et al: A study of the reaction of urea with diacetyl monoxime and diacetyl. Clin Biochem 1972;5:171-181.
16.
Butler AR, Hussain I, et al: The chemistry of the diacetyl monoxime assay of urea in biological fluids. Clin Chim Acta 1981;112:357-360.
17.
Weigmann HJ, Lademann J, et al: Correlation of the local distribution of topically applied substances inside the stratum corneum determined by tape-stripping to differences in bioavailability. Skin Pharmacol Appl Skin Physiol 2001;14:98-102.
18.
Weigmann HJ, Lademann J, et al: Determination of the horny layer profile by tape stripping in combination with optical spectroscopy in the visible range as a prerequisite to quantify percutaneous absorption. Skin Pharmacol Appl Skin Physiol 1999;12:34-45.
19.
Jacobi U, Weigmann HJ, et al: Lateral spreading of topically applied UV filter substances investigated by tape stripping. Skin Pharmacol Physiol 2004;17:17-22.
20.
Ashworth J, Watson WS, et al: The lateral spread of clobetasol 17-propionate in the stratum corneum in vivo. Br J Dermatol 1988;119:351-358.
21.
Ivens UI, Steinkjer B, et al: Ointment is evenly spread on the skin, in contrast to creams and solutions. Br J Dermatol 2001;145:264-267.
22.
Wigger-Alberti W, Maraffio B, et al: Training workers at risk for occupational contact dermatitis in application of protective cream: efficacy of a fluorescence technique. Dermatology 1997;195:129-133.
23.
Weigmann HJ, Lademann J, et al: Bioavailability of clobetasol propionate - quantification of drug concentrations in the stratum corneum by dermatopharmacokinetics using tape stripping. Skin Pharmacol Appl Skin Physiol 1999;12:46-53.
24.
Jacobi U, Schanzer S, Weigmann HJ, Patzelt A, Vergou T, Sterry W, Lademann J: Pathways of lateral spreading. Skin Pharmacol Physiol 2011;24:231-237.
25.
Lademann J, Weigmann HJ, et al: Optical investigations to avoid the disturbing influences of furrows and wrinkles quantifying penetration of drugs and cosmetics into the skin by tape stripping. J Biomed Opt 2005;10:054015.
26.
Van der Molen RG, Spies F, et al: Tape stripping of human stratum corneum yields cell layers that originate from various depths because of furrows in the skin. Arch Dermatol Res 1997;289:514-518.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.